The Trump administration is preparing a major weapons transfer of 2,000‑pound bombs to Israel in the amount of a $2.8 billion package. This transfer is financed largely with the U.S. taxpayer-funded Foreign Military Financing (FMF).
Three major news sources (AP News, Washington Post, Al Jazeera) report the same core facts. The U.S. plans to send 40,000 bombs. These include 20,000 MK‑84s, 20,000 BLU‑117s, and I‑2000 penetrator warheads. The bombs are among the most destructive conventional munitions in the U.S. arsenal.
Why is the U.S. sending these bombs to Israel?
The deal is funded through Foreign Military Financing. This financing comes from money provided by U.S. taxpayers and Israel uses that money to buy U.S. weapons. This is not a commercial sale; it is a U.S.-funded transfer. Since the U.S. views Israel as a key military partner in the Middle East, arms transfers are a long‑standing part of that relationship.
The sale comes amid Israel’s war in Gaza, their operations in Lebanon, and the ongoing regional conflict involving Iran. The Trump administration frames the sale as strengthening Israel’s military capacity during active conflict. While the Biden administration had previously paused one shipment of these bombs due to civilian casualty concerns, Trump lifted that pause upon returning to office.
Humanitarian concerns
These bombs have been used hundreds of times in Gaza and Lebanon, including in areas Israel designated as “safe zones,” contributing to high civilian casualties. The MK‑84 can create craters 35 feet deep, send metal fragments hundreds of meters, and collapse large buildings
Members of Congress, including Sen. Chris Van Hollen, have said they will try to block the sale, arguing that the U.S. should not fund weapons used in mass‑casualty events.
But the Trump administration is sending Israel $2.8 billion in arms because they can use the approved FMF‑funded weapons package. It also fits the long‑standing U.S. policy of supporting Israel militarily. And the administration reversed earlier restrictions tied to humanitarian concerns. The bombs are intended to bolster Israel’s capabilities in ongoing regional conflicts. This is a policy choice, not a legal obligation. As usual, this Trump decision is generating significant debate in Washington.
How can the US afford such a massive transfer when there are reports of military shortages for US operations?
The U.S. can “afford” a $2.8 billion weapons transfer to Israel because it does not come out of the Pentagon’s operational stockpiles and does not compete with munitions needed for U.S. forces. It is financed through a separate budget line called Foreign Military Financing (FMF). The FMF is a State Department program that provides grants to allies to buy U.S. weapons. That distinction is the key to understanding why this transfer can move forward even while U.S. military leaders warn about shortages in certain weapons categories.
FMF is funded by Congress as part of the State Department’s foreign aid budget, not the Defense Department’s procurement or operations accounts. FMF dollars cannot be used to buy U.S. munitions for U.S. forces. They are legally restricted to financing purchases by foreign governments. And Israel is the largest long‑term recipient of FMF grants.
So even if the Pentagon is short on certain weapons, FMF money cannot be redirected to fix those shortages without an act of Congress. This is why the U.S. can approve a $2.8 billion bomb package for Israel while simultaneously facing depleted U.S. stockpiles of artillery shells, strained missile inventories, and production bottlenecks for precision‑guided munitions. These problems exist but they are not funded by the same account.
The 40,000 bombs in the package (MK‑84s, BLU‑117s, and I‑2000 penetrators) are manufactured by U.S. defense contractors and delivered directly to Israel. They are not pulled from U.S existing military stockpiles, so they do not reduce U.S. readiness. This is important because the Pentagon has warned that inventories of 155mm shells are strained, precision‑guided munitions production is behind demand, and American industrial capacity is still ramping up after years of underinvestment
However, the Trump administration argues that the Israel package uses contractor production capacity, not U.S. military stores. And Israel receives a guaranteed multi‑year FMF allocation under the U.S.–Israel Memorandum of Understanding (MOU). FMF is essentially pre‑budgeted, meaning that the money is already appropriated, the administration is executing spending Congress has already approved, and cancelling or repurposing FMF requires new legislation. Thus, even if the Pentagon says it needs more money for U.S. munitions, the FMF funds cannot be repurposed without congressional action.
Critics argue that FMF should be paused when U.S. stockpiles are strained. They also note that U.S. industrial capacity is finite. Producing 40,000 heavy bombs for Israel may slow production of other weapons needed by the U.S. military. And most importantly, the humanitarian impact of 2,000‑lb bombs in Gaza and Lebanon raises moral and strategic concerns.
The Trump administration says that the FMF strengthens a key regional ally, that FMF production lines are distinct from those producing U.S. high‑demand munitions, and that the U.S. defense industrial base benefits economically from FMF‑funded contracts.
Conclusion
The U.S. can send Israel $2.8 billion in bombs because the money comes from FMF, a foreign aid account, not from the Pentagon’s operational or procurement budgets, and the weapons are newly manufactured, not drawn from U.S. military stockpiles. This is why the transfer can proceed even while U.S. commanders warn about shortages in other categories of munitions, and critics point to immoral support of Israel’s war on Palestinians.